Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.
Scientists have aligned themselves with promising but unproven treatments. This story is from Kaiser Health News Renowned Harvard University geneticist David Sinclair recently made a startling ...
Harvard geneticist David Sinclair’s seductive notion that aging is a treatable disease has helped companies he founded to raise more than $1 billion. The investors have almost nothing to show for it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results